BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1746540)

  • 1. Simple method for differentiating between HLA and platelet-specific antibodies by flow cytometry.
    Freedman J; Hornstein A
    Am J Hematol; 1991 Dec; 38(4):314-20. PubMed ID: 1746540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chloroquine or acid treatment of human platelets on the antigenicity of HLA and the 'thrombocyte-specific' glycoproteins Ia/IIa, IIb, and IIb/IIIa.
    Neumüller J; Tohidast-Akrad M; Fischer M; Mayr WR
    Vox Sang; 1993; 65(3):223-31. PubMed ID: 8249366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric detection of platelet-reactive antibodies and application in platelet crossmatching.
    Köhler M; Dittmann J; Legler TJ; Lynen R; Humpe A; Riggert J; Neumeyer H; Pies A; Panzer S; Mayr WR
    Transfusion; 1996 Mar; 36(3):250-5. PubMed ID: 8604511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid treatment of platelets as a simple procedure for distinguishing platelet-specific antibodies from anti-HLA antibodies: comparison with chloroquine treatment.
    Kurata Y; Oshida M; Take H; Furubayashi T; Mizutani H; Tomiyama Y; Yonezawa T; Tarui S
    Vox Sang; 1990; 59(2):106-11. PubMed ID: 2238561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of platelet alloantibodies by flow cytometry.
    Worfolk LA; MacPherson BR
    Transfusion; 1991 May; 31(4):340-4. PubMed ID: 2020999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
    Brubaker DB; Romine M
    Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of immobilized platelet membrane glycoproteins for the detection of platelet-specific alloantibodies in solid-phase ELISA.
    Collins J; Aster RH
    Vox Sang; 1987; 53(3):157-61. PubMed ID: 3318122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approach to eliminate HLA class I antigens from platelet surface without cell damage: acid treatment at pH 3.0.
    Kurata Y; Oshida M; Take H; Furubayashi T; Nakao H; Tomiyama Y; Kanayama Y; Nagao N; Okubo Y; Yonezawa T
    Vox Sang; 1989; 57(3):199-204. PubMed ID: 2617955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of anti-HLA antibodies in sera being tested for platelet reactivity by a platelet lymphocyte immunofluorescence test (PLIFT).
    Muylle L; Van Bockstaele D; De Smet D; Peetermans ME
    J Immunol Methods; 1988 Nov; 114(1-2):187-90. PubMed ID: 3053909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal platelet antibody testing by flow cytometry--results of a pilot study.
    Marshall LR; Brogden FE; Roper TS; Barr AL
    Transfusion; 1994; 34(11):961-5. PubMed ID: 7974704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossmatching on platelets by flow cytometry.
    Wang GX; Terashita GY; Terasaki PI
    Clin Transpl; 1988; ():381-5. PubMed ID: 3154488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloimmunization to platelets in heavily transfused patients with sickle cell disease.
    Friedman DF; Lukas MB; Jawad A; Larson PJ; Ohene-Frempong K; Manno CS
    Blood; 1996 Oct; 88(8):3216-22. PubMed ID: 8874223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A; Picard C
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet alloantibodies in transfused patients.
    Kiefel V; König C; Kroll H; Santoso S
    Transfusion; 2001 Jun; 41(6):766-70. PubMed ID: 11399817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
    Kuntz BM; Wollenhaupt HJ; Brüster HT
    Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and specificity of platelet-specific alloantibodies in HLA-immunized haematologic-oncologic patients.
    Schnaidt M; Northoff H; Wernet D
    Transfus Med; 1996 Jun; 6(2):111-4. PubMed ID: 8809957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Platelet phenotyping and study of alloantibodies using flow cytometry].
    Vergracht A; Valentin N; Bignon JD; Patereau C; Muller JY
    Rev Fr Transfus Immunohematol; 1988 Dec; 31(5):697-709. PubMed ID: 3070706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic analysis of three cases of neonatal alloimmune thrombocytopenia associated with HLA antibodies.
    Saito S; Ota M; Komatsu Y; Ota S; Aoki S; Koike K; Tokunaga I; Tsuno T; Tsuruta G; Kubo T; Fukushima H
    Transfusion; 2003 Jul; 43(7):908-17. PubMed ID: 12823751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody.
    Kao KJ; Cook DJ; Scornik JC
    Blood; 1986 Sep; 68(3):627-32. PubMed ID: 3742047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.